Despite decades of advancing science and clinical trials, average survival remains dismal for individuals with high-grade gliomas. Our understanding of the genetic and molecular aberrations that contribute to the aggressive nature of these tumors is continually growing, as is our ability to target such specific traits. Herein, we review the major classes of such targeted therapies, as well as the relevant clinical trial outcomes regarding their efficacy.
CITATION STYLE
Jordan, J. T., & Wen, P. Y. (2015). Novel chemotherapeutic approaches in adult high-grade gliomas. Cancer Treatment and Research, 163, 117–142. https://doi.org/10.1007/978-3-319-12048-5_8
Mendeley helps you to discover research relevant for your work.